Radiogenomics analysis reveals the associations of dynamic contrast-enhanced-MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer.

In the validation cohort, BC samples were stratified by the mean of MRI_RiskScore, and highly significant differences in DFS were observed between high- and low-risk samples ( Figure 6B , log-rank p -value < 0.0001).

also in 132,142 other papers